Literature DB >> 21570091

Synuclein deposition and non-motor symptoms in Parkinson disease.

Kurt A Jellinger1.   

Abstract

Parkinson disease (PD) is a multisystem neurodegenerative disorder clinically characterized by motor and non-motor (NM) symptoms. The causes of NM symptoms in PD, many of which antedating motor dysfunction, are multifocal and unlikely explained by single lesions. They include olfactory, autonomic, sensory, skin, sleep, visual, neuropsychiatric, and other manifestations. Most NM features in PD are related to α-synuclein pathology which, in addition to the dopaminergic striatonigral system, involves non-nigral brainstem nuclei, sympathetic, parasympathetic, enteric and pelvic plexuses, cardiac systems, submandibular gland, adrenal medulla, skin, retina, and other visceral organs. This suggests a topographical and chronological spread of lesions, particularly in the prodromal stages of the disease, which, however, awaits further confirmation. A few animal models are available that recapitulate NM symptoms in human PD, but their validity is under discussion. More studies are warranted to refine the exact correlations between presymptomatic and late-developing NM features of PD and α-synuclein pathology as a basis for more effective preventive and therapeutic options of this devastating disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570091     DOI: 10.1016/j.jns.2011.04.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  33 in total

Review 1.  α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.

Authors:  Sushil K Singh; Aloke Dutta; Gyan Modi
Journal:  Future Med Chem       Date:  2017-06-20       Impact factor: 3.808

2.  Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Authors:  Jing Zhao; Xun Han; Li Xue; Konghua Zhu; Hongxin Liu; Anmu Xie
Journal:  Neurol Sci       Date:  2015-04-25       Impact factor: 3.307

Review 3.  Parkinson's disease as a multisystem disorder.

Authors:  Lisa Klingelhoefer; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2017-02-02       Impact factor: 3.575

Review 4.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

5.  Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.

Authors:  Luca Toti; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

Review 6.  Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.

Authors:  Hiroyasu Sato; Takeo Kato; Shigeki Arawaka
Journal:  Mol Neurobiol       Date:  2014-08-21       Impact factor: 5.590

7.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

8.  Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.

Authors:  Shi Zhang; Erez Eitan; Tsung-Yu Wu; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2017-09-22       Impact factor: 4.673

9.  Macrophages are unsuccessful in clearing aggregated alpha-synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats.

Authors:  Robert J Phillips; Cherie N Billingsley; Terry L Powley
Journal:  Anat Rec (Hoboken)       Date:  2013-02-26       Impact factor: 2.064

10.  Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.

Authors:  Joseph J Locascio; Shirley Eberly; Zhixiang Liao; Ganqiang Liu; Ashley N Hoesing; Karen Duong; Ana Trisini-Lipsanopoulos; Kaltra Dhima; Albert Y Hung; Alice W Flaherty; Michael A Schwarzschild; Michael T Hayes; Anne-Marie Wills; U Shivraj Sohur; Nicte I Mejia; Dennis J Selkoe; David Oakes; Ira Shoulson; Xianjun Dong; Ken Marek; Bin Zheng; Adrian Ivinson; Bradley T Hyman; John H Growdon; Lewis R Sudarsky; Michael G Schlossmacher; Bernard Ravina; Clemens R Scherzer
Journal:  Brain       Date:  2015-07-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.